pharmacodynamics

 

1. Introduction to Pharmacodynamics

  • Definition: Pharmacodynamics is the study of the biochemical and physiological effects of drugs on the body, and the mechanisms by which these effects are produced.

 

  • Therapeutic Objective: The goal is to achieve the desired therapeutic effect of a drug while minimizing adverse effects. Understanding pharmacodynamics helps in patient education, making PRN decisions, evaluating drug responses, and collaborating on drug therapy.

 

2. Dose-Response Relationships

  • Key Concepts:

    • Relationship: This refers to the correlation between the dose of a drug and the intensity of the response it produces.

 

  • Phases: Three phases of the dose-response curve help in understanding the minimum effective dose, the maximum achievable effect, and the dosage adjustments needed to increase response.

 

 

  • Clinical Application: Tailoring treatment involves adjusting the dosage to achieve the desired intensity of response.

 

3. Maximal Efficacy and Relative Potency

  • Maximal Efficacy:

    • Definition: The largest effect that a drug can produce (height of the dose-response curve).

 

  • Clinical Relevance: The intensity of the response should match the patient's need; higher maximal efficacy is not always better.

 

  • Relative Potency:

    • Definition: The amount of drug required to produce an effect. Potency is not necessarily related to the maximal efficacy of the drug.

 

  • Clinical Relevance: Important when a drug’s low potency necessitates large doses, which may be inconvenient or less safe.

 

4. Drug-Receptor Interactions

  • Drugs:

    • Chemicals that produce effects by interacting wiith other chemicals

  • Receptors:

    • Definition: Functional macromolecules in cells with which drugs interact to produce effects. These include enzymes, ribosomes, and tubulin but are usually associated with hormones, neurotransmitters, and regulatory molecules.

 

  • Binding:

    • Mechanism: The binding of a drug to its receptor is generally reversible. The drug may mimic or block the action of endogenous molecules, thus altering physiological activity. Drugs cannot give cells  new functions

 

  • Types of Receptors:

    • Four Primary Families:

      1. Cell membrane-embedded enzymes

      2. Ligand-gated ion channels

      3. G-protein coupled receptor systems

      4. Transcription factors

  • More selective a drug is, fewer side effects it will produce

  • Lock and key mechanism

  • Affinity: strength of the attraction

  • Intrinsic activity: ability of the drug to activate a receptor upon binding

5. Agonists and Antagonists

  • Agonists:

    • Function: Activate receptors, mimicking the action of endogenous substances.

      • Have affinity and high intrinsic activity (ask chat to simplify)

 

  • Effect: Can increase or decrease physiological processes depending on the receptor. Make processes go faster or slower

 

  • Antagonists:

    • Function: Prevent receptor activation by endogenous molecules and other drugs.

      • They have affinity but no intrinsic activity, meaning they do not activate receptors but block agonist effects.

 

  • Types of Antagonists:

    • Noncompetitive: Bind irreversibly to receptors( hook up and never let go), reducing the maximal response that agonists can elicit.

 

  • Competitive: fight with agonists for receptor binding and bind reversibly.

    • Equal affinity: receptor occupied by whichever agent is oresent un the highest concentration

 

  • Partial Agonists:

    • Definition: Have moderate intrinsic activity, producing a weaker response than full agonists. They can act as both agonists and antagonists.

 

6. Regulation of Receptor Sensitivity

  • Dynamic Nature of Receptors:

    • Receptor sensitivity can change due to continuous exposure to drugs:

      • Downregulation: Desensitization due to continuous activation.

      • Upregulation: Increased sensitivity due to continuous inhibition.
         

 

  • Clinical Implication: Adjusting drug dosages is necessary when receptors become desensitized or hypersensitive.

 

7. Drug Responses That Do Not Involve Receptors

  • Receptorless Drugs:

    • Examples: Antacids, chelating agents, osmotic diuretics, and laxatives. (works on gut but doesn’t hook up to cell)

 

  • Mechanism: These drugs produce effects through simple physical or chemical interactions rather than binding to receptors.

 

8. Interpatient Variability in Drug Responses

  • Variability: Patients may respond differently to the same drug dose due to genetic, physiological, and environmental factors.

 

  • Clinical Approach: Initial doses are estimates and require adjustment based on the patient’s response (fine-tuning).

 

9. Therapeutic Index

  • Definition: A measure of a drug’s safety, calculated as the ratio between the lethal dose (LD50) and the effective dose (ED50).

 

  • Clinical Significance:

    • High Therapeutic Index: Indicates a safer drug.

 

  • Low Therapeutic Index: Indicates a drug that requires careful dosage and monitoring.

 

10. Questions for Review

  • Sample Questions:

    1. What effect does a competitive antagonist have when administered in the presence of an agonist?

    2. Why is maximal efficacy more important than potency in clinical settings?